drugset / Trial / NCT05788627

Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy

NCT05788627

Phase 4 Unknown 100 enrolled Khyber Medical College, Peshawar
RandomizedParallel-groupSingle-blindTreatment

Summary

Patients with chronic liver disease due to hepatitis B or C viruses, Non-alcoholic fatty liver disease, autoimmune hepatitis, wilson disease, cryptogenic hepatitis etc are prone to develop complications. Hepatic encephalopathy is one of such complications. It is graded into four types depending on severity of clinical features, which range through altered sleep pattern to coma. The current study aims to compare the effectiveness of lactulose enema with oral lactulose in time to recovery from higher grade of encephalopathy to lower grade of encephalopathy.

Timeline

Start
2023-04
Primary completion
2023-09
Completion
2023-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactulose Other / unclassified 30 ml Oral
Subject Lactulose Other / unclassified 300 ml Oral